BMRN
BioMarin Pharmaceutical
BMRN
Meridian score15
ResearchNot researched
QualityQuality: 13th percentile
MomentumMomentum: 71st percentile
GrowthGrowth: 0th percentile
ValuationValuation: 68th percentile
ExpectationsExpectations: 89th percentile
Evidence to review
- Financial comparability: Goodwill and intangible assets increased materially; review acquisition effects.
- Financial comparability: Leverage changed across a non-comparable reporting window.
Price and trend
Price$55.35
1M-6.9%
3M-9.8%
6M+3.8%
52w position28.0%
From high-22.0%
Relative volume1.0x
As ofOct 27, 2026
Above 21d: noAbove 50d: noAbove 200d: no50d over 200d: yes